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Introduction
Somatic mosaicism is defined as the presence of genetically distinct populations of somatic cells in a given organism 1 . Although somatic mosaicism is assumed to be frequently masked, it can also result in major phenotypic changes and reveal the expression of otherwise lethal genetic mutations. Mosaicism can be caused by DNA mutations, epigenetic alterations of DNA, chromosomal abnormalities and the spontaneous reversion of inherited mutations.
Similar to somatic mosaicism due to de novo mutations during embryogenesis, mosaicism due to reversions to normal of an inherited mutation have been discovered because of milder than expected clinical course and/or presence of both phenotypically normal and abnormal cells in vivo and in vitro 2 . In case of spontaneous reversion, the mutation that has reverted to normal in some cells, has been inherited from a parent.
Establishment of significant somatic mosaicism following reversion to normal could modify disorders in which revertant cells have a selective advantage in vivo. The rate of cell turnover may be a factor that contributes to the chance of spontaneous reversion as such. Most spontaneous reversions have been identified to occur in severe skin disease and hematological or immunological diseases [2] [3] [4] [5] [6] . The growth advantage of revertant cells has been the central dogma for the success of gene therapy in severe combined immunodeficiency (SCID) 7, 8 .
SCID is a collection of various gene defects that result in the absence of T lymphocytes with or without the involvement of B cells and/or NK cells 9 . To date, spontaneous gene reversions have been reported in several patients suffering from ADA-SCID [10] [11] [12] [13] [14] . This form of SCID is causing metabolic disease is due to defective adenine deaminase (ADA) activity in all cells.
As it has turned out, lymphocytes are particularly sensitive to the toxic effects of the accumulating purine metabolites in ADA deficiency. Reversed mutations have also been found in patients with Wiskott-Aldrich syndrome [15] [16] [17] and other primary T cell immunodeficiencies such as those caused by mutations in CD3zeta, RAG-1, LAD and NEMO 5, [18] [19] [20] [21] . The most common type of SCID in humans shows X-linked inheritance and is caused by mutations in the IL2RG gene 22, 23 . This gene encodes an essential subunit, the common γ-chain (γ c , CD132), of a cytokine receptor subfamily that is essential for lymphocyte development, T cell homeostasis, and peripheral immune responses 24 . To date, only three examples of gene reversion of an inherited mutation have been reported in X-linked SCID which were in all three cases in the common T cell precursors, hence resulting in reverted CD4 + and CD8 + T cells of both TcRαβ and TcRγδ signature [25] [26] [27] .
CD132 is a type I transmembrane glycoprotein that serves as a subunit for the receptors (R) of IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21. The IL-2R and IL-15R are heterotrimers comprised of unique α-chains and shared IL-2Rβ (CD122) and the CD132 subunit, whereas the IL-4R, IL-7R, IL-9R, and IL-21R are heterodimers of unique α-subunits and CD132. For each of the receptors CD132 contributes to ligand binding affinity, but also to signal transduction through the direct association of Jak-3 to its cytoplasmic tail [22] [23] [24] 28 . Mutations in CD132 abolish the function in each of these cytokine receptors, resulting in the absence or diminished numbers of T and NK cells, while B cell development is normal. X-SCID is diagnosed early in life, but some exceptional cases and families have been reported in which CD132 mutations resulted in an immunological phenotype distinct from classical X-SCID [29] [30] [31] [32] [33] [34] . These so-called X-CID (combined immune deficiency) patients may have impaired rather than absent function of CD132.
Mosaicism due to somatic gene reversion has been observed in the immune system as well as in various other disease entities 1-6, 17, 35-37 .
Here we report a novel X-(S)CID family with a unique mutation in the extracellular part of 
Methods
Detailed methods are provided in the online supplemental material.
Samples
Heparinized peripheral blood samples were collected from the patient longitudinally. PBMC were isolated using standard density gradient centrifugation techniques and in some instances cryopreserved until use. The patient's samples were analyzed simultaneously with PBMC 
T-cell receptor repertoire analysis by high throughput sequencing
The T-cell receptor repertoire of sorted cell populations was analyzed as previously described 41, 42 . The Complementarity Detemining Region (CDR)-3 of the TCR-β-chain was used as clonal tag to identify individual clones. Briefly, mRNA was isolated and cDNA was synthesized. In the first step of linear amplification (LA) cDNA was amplified using a modified version of the Vβ primerset described by Dongen et al 43 . All V-primers were tailed with the primerB sequence needed for sequencing according to the 454 Titanium protocol for
Amplicon sequencing (Roche Diagnostics, Mannheim, Germany). In this article we will use the HUGO nomenclature according to Folch and Lefranc 44 . After LA a generic PCR was
Results
These studies were performed to diagnose and further elucidate the molecular disease mechanism of a male patient, who is the off-spring from a non-consanguineous, Caucasian family, and frequented the pediatric pulmonology department because of repeated infectious disease. Initial immunological screening did not point in the direction of any immunological diagnosis at this stage. Also the humoral immune response upon vaccination was tested positive.
When the patient was brought to our attention at the age of 6 years, two notable findings were suspicious. First, the mother's twin brother had died at the age of 14 years from an unexplained disease with liver failure and progressive bronchiectasis. He had been diagnosed at that time with acrodermatitis eczematicum in the presence of a low serum zinc and/or a less penetrant form of cystic fibrosis (CF), which could not be diagnosed at the DNA level back then. Secondly, the index-case was covered with molluscum contagiosum virus (MCV) lesions, which had not resolved after three years.
We tested serology again and found the complete absence of antibodies against the standard immunizations that he had received in the past (including measles-mumps-rubella (MMR), diphtheria toxoid-tetanus toxoid-inactivated pertussis-polio (DTP-polio) vaccines). EBV and CMV titers were screened as well as the VZV serology since he had suffered from mild chickenpox in the past. All serological tests were negative, in the presence of normal total values for IgG (12.6 g/L), IgA (0.58 g/L) and IgM (0.89 g/L). Upon repeating the immunizations against pneumococcal polysaccharides (PPS; 23-valent Pneumovax), tetanus toxoid and MMR, we observed a normal induction of antibodies. However, upon follow-up the antibodies had completely disappeared within 2-4 months to undetectable levels again.
High resolution CT scanning showed the presence of bronchiectasis. Cystic fibrosis was excluded at the DNA level, zinc levels were normal, other liver/lung diseases were excluded, including α1-antitrypsin deficiency and primary ciliary disease. The patient was put on monthly infusions of intravenous immunoglobulins (IVIG) and co-trimoxazole prophylaxis.
His skin was enucleated in a 3-hour course of "peeling", but molluscum contagiosum lesions returned and disseminated again. During follow-up the clinical course improved considerably.
Over the last 7 years he has suffered only once from an atypical pneumonia caused by
Mycoplasma pneumoniae, which responded favorably to macrolide antibiotics and after several years his molluscum contagiosum started to disappear spontaneously.
Lymphocyte counts and subsets
As indicated by the absolute lymphocyte counts, all subsets were in the low-normal range and remained stable apart from the absolute numbers of CD8 + T cells which increased over time and reached very high numbers resulting in an inverted 4/8 ratio ( Figure 1A ). T cell subset analysis showed decreased percentages of naïve (CD45RA + CD27 + ) CD4 + and CD8 + T cells for age concomitant with increased percentages of memory T cells (CD45RA − CD27 + ), especially in the CD8 + T cell subset ( Figure 1B ). This disturbed CD8 + T cell differentiation progressed over the years ( Figure 1C ), whereas little change was seen in CD4 + T cell differentiation. TREC levels in CD3-sorted T-cells were within the normal range (data not shown). In the circulating B cell fraction, there was a notable lack of switched-memory B cells with the IgD − CD27 + phenotype (< 2% over time; normal age-matched range 6-15%) ( Figure 1B ).
Lymphocyte proliferation tests and cytokine receptor expression
We tested his CD4 + and CD8 + T cells for αCD3/αCD28 mediated proliferation using CFSE dilution and this was completely normal; almost all T cells underwent several rounds of division ( Figure 2A ). The antigen-specific memory responses were defined by assessment of T-cell responsiveness against CMV, VZV, tetanus toxoid and Candida albicans. Although the boy had been frequently boosted with tetanus toxoid, was infected by chickenpox in the past, and must have been colonized by Candida albicans before, no appropriate reaction to these stimuli could be detected ( Figure 2B ). However, γc-cytokine induced proliferation of T and NK cells was strongly diminished.
Mutation analysis of the IL2RG gene was performed on DNA isolated from total leukocytes of the index patient and showed a single nucleotide substitution (c.655A>T) representing a missense mutation resulting in a change at amino acid position 219 from a tyrosine into an asparagine residue (p.Tyr219Asn). In addition to the mutated allele, a wild type allele was detected, although at lower frequency.
The boy had no stigmata of Klinefelter disease (XXY) that could explain the presence of two
alleles. An alternative explanation for this genetic finding was the presence of circulating maternal T cells. However, this was formally excluded by HLA-genotyping and short tandem repeat (STR) marker analysis. Therefore, we concluded that the wild type allele originated from somatic reversion. To determine in which lymphocyte subpopulation the reversed wild type allele was present, patient's CD19 + B cells, CD3 − CD16/56 + NK cells and CD3 + T cells were sorted from peripheral blood followed by sequence analysis. In T cells the mutated and the reversed wild type IL2RG allele were detected with a similar frequency, whereas in B and NK cells only the mutated allele was present ( Figure 4B ). In summary, the patient had a missense mutation in the ILR2G gene that had been reverted to a wild type allele in approximately half of the T cells.
IL2RG mutation analysis in sorted T-cell subsets
Over the years the number of CD8 + T cells increased and this increase was observed in the memory fraction ( Figure 1C) . To determine in which T-cell subset the reverted allele was present and whether this influenced the observed changes over time in dominance of the CD8+ T cell subset, CD4 + and CD8 + naïve (CD45RA + CD27 + ), memory (CD45RA − CD27 + ), and effector (CD45RA − CD27 − ) T cells were sorted and the frequency of reversion was determined at two time points (t=0 and t=2 years). In naïve CD4 + T cells only the nonreverted, mutated allele was detected at both time points, in memory CD4+ T cells only a small percentage was reverted (Supplemental Table 1 ). At the second time point 40% of the usually small fraction of CD4 + CD27 − effector T cells was found to contain the reverted allele ( Figure 4C ). In contrast, 5% of the naïve CD8 + T cells and 25% of memory CD8 + T cells had the reverted allele, which increased to 40% of the naïve CD8 + T cells and 90% of memory CD8 + T cells in a period of two years. The effector CD8 + T cells had a reversion frequency of 80% (t=2 years). Finally, in two additional sorts from different time points, TCRγδ + T cells were isolated and in this T cell population the reversion frequency was stable at 20%
(Supplemental Table 1 ). These results showed that the reverted allele was present in different T cell lineages, indicating a progenitor T cell as common source of the circulating revertant T cells.
Properties of the CD8 + T cell population
When the findings on partial gene reversion became apparent, we tested for the expression of CD132 expression and clonal composition, both in the naïve and memory CD4 + and CD8 + compartments. CD132 expression was tested upon activation of the PBMC for 3 days with αCD3/αCD28 MoAbs. In contrast to the very low CD132 expression on activated CD4 + T cells, CD132 expression was clearly present on CD8 + T cells after stimulation ( Figure 5 ). Figure 6A ). This was further confirmed by the diverse use of the (variable) genes of the TCR-β-chain ( Figure 6B ). This broad repertoire indicates that normal VDJ-rearrangement had taken place in the naive T cell subset, which is similar to that of healthy individuals. The non-revertant component may have contributed to the fully diversified repertoire of the memory CD8 T + cell subset but as this is a relatively small fraction of the total cell population it seems unlikely that the full diversity can be attributed to these cells. Thus, the revertant populations were highly diverse in their TCR repertoire and not oligoclonal of nature.
Discussion
In this study we describe a novel family with non-classical X-(S)CID and a spontaneous reversion of the genetic defect that was identified in part of the CD8 + T cells. The patient was admitted with recurrent pulmonary infections and widely spread molluscum contagiosa virus lesions on his skin. The X-linked pattern of inheritance combined with the defect in cytokinemediated T cell proliferation led to the identification of a missense mutation in the gene coding for CD132 (IL2RG) (c.655A>T).
This mutation has not been described before ( To date, only three cases of IL2RG gene reversion have been reported at the T-cell precursor stage [25] [26] [27] . A reversion of a specific deleterious point mutation is statistically highly unlikely.
However, in vivo selection could allow such a rare event, because any reversion of the inherited IL2RG mutation in T cells would confer a distinct advantage over cells without functional CD132 chains in terms of growth and differentiation. In our case, only partial gene reversion was observed to be present in the T cells. This could be explained by the hypomorphic nature of the IL2RG mutation that still allowed T and NK cell development to occur, which would fit with the belated clinical presentation.
All reverted T cells in the patients reported thus far arose from a single revertant T cell precursor, as was confirmed by the polyclonal T cell repertoire 46 . Also in our patient the T A common theme is the selective survival advantage of the revertant immune cells over mutant cells, which has been amply discussed in terms of its implications for gene therapy.
Our data confirm the developmental potential of a single T cell precursor in humans with broadly diverse T cell repertoire 25, 26 . The mutations in these two cases also predicted amino acid substitutions (p.Cys115Arg and p.Leu151Pro, respectively) in the extracellular part of the protein 25, 26 , but had -in contrast to our case -a more global T cell pattern of gene CD132 expression on lymphocyte subsets upon 3-day stimulation using antiCD3/antiCD28
Moabs. Filled histograms: unstimulated cells, black line: activated cells.
Figure 6. TCR-β analysis in reverted cells shows a diverse repertoire.
A : CD8 + CD45RA − (memory) subset and the CD8 + CD45RA + CD27 + (naïve) were sorted using FACS (>95% purity). Both samples were prepared for high throughput sequencing using a primerset that covers the complete TCR-β repertoire. From both samples approximately 10,000 TCR-β sequences were sequenced using high throughput sequencing. Each clone is depicted as a dot showing its relative frequency to the complete subset (percentage of total reads). As comparison we used control samples.
B:
Vβ-usage of the same samples used in A was determined. Use of V-genes (and J-genes, data not shown) was comparable to healthy controls (data not shown). # c e l l s # c e l l s 
T-cell receptor repertoire analysis by high throughput sequencing
The T-cell receptor repertoire of sorted cell populations was analyzed as previously described 41, 42 . The Complementarity Detemining Region (CDR)-3 of the TCR-β-chain was used as clonal tag to identify individual clones. Briefly, mRNA was isolated using the RNeasy Mini System (Qiagen, Venlo, the Netherlands). cDNA was synthesized with Superscript RT-III and oligo-dT primers according to the manufacturer's protocol (Invitrogen Life Technologies, Breda, NL). In the first step of linear amplification (LA) cDNA was amplified using a modified version of the Vβ primerset described by Dongen et al 43 . All V-primers were tailed with the primerB sequence needed for sequencing according to the 454 Titanium protocol for Amplicon sequencing (Roche Diagnostics, Mannheim, Germany). In this article we will use the HUGO nomenclature according to Folch and Lefranc 44 .
In the first step of LA the cDNA is amplified in the presence of 5 pmol of each of the 23 Vprimers (Biolegio, Nijmegen, the Netherlands), 1x buffer B (Solis BioDyne, Tartu, Estonia), 1mM MgCl 2 , 0.1 mM dNTPs and 3U of Hotfire (Solis BioDyne) in a volume of 20 uL using a T-Professional thermocycler (Biometra, Goettingen, Germany). Amplified products were purified using AMPure XP SPRI-beads (Agencourt Bioscience, Beverly, US). After LA a generic PCR was performed to prepare the samples for sequencing. In this second reaction primerB is used as generic forward primer and a generic primer specific for the TCR-β constant gene segment (CTCAAACACAGCGACCTC) as reverse primer. The reverse primer is tailed with a multiplex identifier and primerA as described in the amplicon sequencing manual. After amplification, the samples are purified using the AMPure beads and quantified using fluorospectometry and prepared according to the manufacturer's protocol for Amplicon
Sequencing on a Roche Sequencer FLX using the Titanium platform. Over >40,000 (beadbound) TCR sequences were analyzed. 
